This is the limited version of the American Cyanamid company profile: Join LinkedIn or Sign In to see more information.
Trius Therapeutics, Inc. designs small molecule drugs with novel modes of action. Its drugs are useful in a range of bacterial infections, including those caused by resistant bacteria. The company applies structure-based drug design technology to design multiple safe and specific inhibitors. Trius Therapeutics, Inc. was formerly known as Rx3 Pharmaceuticals, Inc. The company was founded in 2004 and is based in San Diego, California.
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com Copyright © 2008 Capital IQ
This LinkedIn Company Profile was created by LinkedIn and is about American Cyanamid. This page is not endorsed by or affiliated with American Cyanamid. For questions regarding LinkedIn Company Profiles, contact us.
American Cyanamid full company profile, top executives, board of directors & more.
| 